$7.17
-0.23-3.11%
At close: -
$7.17
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Immunome Insider Trading Activity | NASDAQ:IMNM | Benzinga
Track the latest Immunome insider trading activity. Stay informed on recent buys, sells, and market impact for Immunome stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Immunome Inc Insiders Doing?
At Immunome Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 164.20K shares for a total value of $1.22M.
Notable Recent Insider Buys and Sales
- On February 3, 2025, CLAY SIEGALL, the company's PRESIDENT AND CEO purchased 150K shares for $7.75 each.
- On March 26, 2025, CLAY SIEGALL, the company's PRESIDENT AND CEO purchased 137.1K shares for $7.29 each.
- On March 25, 2025, Philip Tsai, the company's CHIEF TECHNOLOGY OFFICER purchased 12.3K shares for $8.42 each.
Ownership Statistics for Immunome Inc
Shares Outstanding
86.951M
Insider Shares Owned
3.728M
Insider Percentage Owned
4.29%
Institutional Shares Held
34.308M
Institutional Percentage Held
39.5%
| Mar 26, 2025 | JACQUES JEAN BIENAIME | — | 7.80K | $7.78 | $60.68K | BUY | 33.03% | 31.41K | Mar 25 | View |
| Mar 26, 2025 | CLAY SIEGALL | PRESIDENT AND CEO | 137.10K | $7.29 | $999.46K | BUY | 20.47% | 806.74K | Mar 26 | View |
| Mar 25, 2025 | JACQUES JEAN BIENAIME | — | 7.00K | $8.21 | $57.47K | BUY | 42.13% | 23.61K | Mar 24 | View |
| Mar 25, 2025 | Philip Tsai | CHIEF TECHNOLOGY OFFICER | 12.30K | $8.42 | $103.57K | BUY | 58.57% | 33.30K | Mar 24 | View |
| Feb 03, 2025 | CLAY SIEGALL | PRESIDENT AND CEO | 150.00K | $7.75 | $1.16M | BUY | 28.87% | 669.64K | Jan 31 | View |
| Nov 25, 2024 | CLAY SIEGALL | PRESIDENT AND CEO | 100.00K | $9.62 | $962.18K | BUY | 23.83% | 519.64K | Nov 21 - Nov 22 | View |
| Nov 25, 2024 | Robert Lechleider | CHIEF MEDICAL OFFICER | 15.80K | $9.48 | $149.80K | BUY | ∞ | 15.80K | Nov 21 | View |
| Nov 25, 2024 | Philip Tsai | CHIEF TECHNOLOGY OFFICER | 21.00K | $9.43 | $198.03K | BUY | ∞ | 21.00K | Nov 21 | View |
| Sep 20, 2024 | Max Rosett | CHIEF FINANCIAL OFFICER | 27.62K | $8.53 | -$186.12K | SELL-OPTIONS | 139.10% | 47.48K | Sep 19 | View |
| Aug 19, 2024 | JACQUES JEAN BIENAIME | — | 7.00K | $13.94 | $97.61K | BUY | 72.80% | 16.61K | Aug 16 | View |
| Aug 19, 2024 | Jack Higgins | CHIEF SCIENTIFIC OFFICER | 13.53K | $7.64 | -$22.71K | SELL-OPTIONS | ∞ | 13.53K | Aug 15 - Aug 19 | View |
| May 22, 2024 | JACQUES JEAN BIENAIME | — | 2.00K | $13.57 | $27.14K | BUY | 26.26% | 9.62K | May 21 | View |
| May 21, 2024 | CLAY SIEGALL | PRESIDENT AND CEO | 100.00K | $13.88 | $1.39M | BUY | 31.29% | 419.64K | May 20 - May 21 | View |
| Oct 04, 2023 | CLAY SIEGALL | PRESIDENT AND CEO | 169.20K | $5.91 | $1000.00K | BUY | 112.48% | 319.64K | Oct 02 | View |
| Oct 04, 2023 | Bruce Turner | CHIEF STRATEGY OFFICER | 42.30K | $5.91 | $249.99K | BUY | ∞ | 42.30K | Oct 02 | View |
| Sep 14, 2021 | MICHAEL RAPP | DIRECTOR | 25.96K | $19.96 | $518.20K | BUY | 2.64% | 1.01M | Sep 13 | View |
| Sep 13, 2021 | MICHAEL RAPP | DIRECTOR | 45.95K | $18.07 | $830.45K | BUY | 4.91% | 982.65K | Sep 09 - Sep 10 | View |
| May 26, 2021 | Michael Lefenfeld | DIRECTOR | 4.65K | $18.53 | $86.15K | BUY | 20.93% | 26.87K | May 24 - May 26 | View |
| May 26, 2021 | MICHAEL RAPP | DIRECTOR | 53.50K | $18.38 | $983.42K | BUY | 6.06% | 936.70K | May 24 - May 26 | View |
| May 26, 2021 | PHILIP WAGENHEIM | DIRECTOR | 13.50K | $18.35 | $247.73K | BUY | 3.52% | 397.40K | May 24 | View |
| May 26, 2021 | Purnanand D Sarma | PRESIDENT AND CEO | 10.50K | $18.41 | $193.31K | BUY | ∞ | 10.50K | May 25 | View |
| May 26, 2021 | JOHN LAMATTINA | DIRECTOR | 5.44K | $18.57 | $101.03K | BUY | 11.73% | 51.83K | May 24 | View |
| Oct 08, 2020 | MICHAEL RAPP | — | 638.89K | $12.00 | $999.98K | DERIVATIVE CONVERSION | 77.19% | 1.47M | Oct 06 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.